title: [Long-term follow-up of bilateral endogenous Klebsiella endophthalmitis].
abstract: BACKGROUND
  Endophthalmitis subsequent to Klebsiella sepsis leads to functional blindness in most cases and is very difficult to treat. Every successful therapeutic modality can therefore help in creating an optimal therapeutic plan.
  
  
  METHODS
  A 69-year old diabetic patient exhibited bilateral Klebsiella endophthalmitis with sepsis after a pneumonia. Two intravenous antibiotics were used: aminoglycosides (Gentamycin) and cephalosporins (Cefotaxim or Cefuroxim) with local parabulbar injections of Prednisolon. The long-term follow-up of four years provided some overview of morphological aspects of the development of endophthalmitis. Characteristic greyish hypopyon was seen in both eyes, which was more pronounced in the left eye than in the right. The left eye became phthisic. After resorption of the hypopyon in the right eye and prolonged resorption of the subretinal abscess for 9 months a useful visual acuity at 0.2 was achieved. Two years after the endophthalmitis a cataract surgery with implantation of a posterior chamber silicon lens was performed and good visual acuity (0.6) was achieved. After four years, the subretinal abscess left an extremely large, sharp bordered, unpigmented scar up to the sclera.
  
  
  CONCLUSIONS
  An early diagnosis and adequate long-time antibiotic therapy under the co-operative supervision of an ophthalmologist with internist appears to be most important for the therapeutic success in Klebsiella endophthalmitis.
authors.affiliation: Gemeinschaftspraxis der Augenärzte im Rudolf-Virchow-Arztehaus, Salzgitter.
authors.forename: Heinrich
authors.initials: H
authors.lastname: Holak
authors.forename: Reinhard
authors.initials: R
authors.lastname: Becker
authors.forename: Sophie
authors.initials: S
authors.lastname: Holak
mesh_terms: D000038:Abscess / Q000175:diagnosis / Q000188:drug therapy; D000368:Aged; D002439:Cefotaxime / Q000008:administration & dosage; D002444:Cefuroxime / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D009877:Endophthalmitis / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D007710:Klebsiella Infections / Q000175:diagnosis* / Q000188:drug therapy; D007910:Lenses, Intraocular; D008134:Long-Term Care; D008297:Male; D009887:Ophthalmoscopy; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D005839:Gentamicins; D011239:Prednisolone; D002439:Cefotaxime; D002444:Cefuroxime